JP Patent

JP6333289B2 — トランスサイレチン安定剤並びにトランスサイレチン・アミロイドーシス及びタンパク質−タンパク質相互作用を抑制するためのそれらの使用

Assigned to Leland Stanford Junior University · Expires 2018-05-30 · 8y expired

What this patent protects

Patent listed against acoramidis-hydrochloride.

Drugs covered by this patent

acoramidis-hydrochloride (ACORAMIDIS HYDROCHLORIDE)

Patent Metadata

Patent number: JP6333289B2
Jurisdiction: JP
Classification: —
Expires: 2018-05-30
Drug substance claim: No
Drug product claim: No
Assignee: Leland Stanford Junior University
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.